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cDNAs encoding rat adipose tissue hormone-sensitive lipasc were expressed in COS cells, urder the control of the SV40 promoter to half the level 
in rat adipocytes. the richest native source of the enzyme. A cDNA lacking most of the long Y-untranslated region of the full-length rat 
hormone-sensitive lipase cDNA was, with regard to the lipase activity, on the average 70% more efficiently expressed than the full-length cDNA. 
The recombinant protein was almost identical to hormone-sensitive lipase of rat adipose tissue with respect to specific activity, susceptibility to 
inhibitors, molecular size, phosphorylation and activation by cyclic AMP-dependent protein kinase. The described eukaryotic expression system 
will allow analysis of effects of amino acid substitutions introduced into the lipase molecule by site-directed mutagenesis. 
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1, INTRODUCTION 
Hormone-sensitive lipase (HSL) is a key enzyme in 
lipid metabolism and overall energy homeostasis in 
mammals. It catalyzes the rate-limiting step in the 
breakdown of stored triacylglycerols in adipose tissue, 
i.e. the hydrolysis of triacylglycerols to diacylglycerols 
[1,2]. HSL is also present in the steroidogenic tissues 
[3-61, where it functions as a cholesterol ester hydrolase 
and has been proposed to play an important regulatory 
role in the synthesis [3] and also hydrolysis [7] of steroid 
hormones from these tissues. The activity of HSL is 
under strict hormonal and neural control, a mechanism 
involving phosphorylation of a single serine residue 
(Ser-563) [6,8] by cylic AMP-dependent protein kinase 
[9,10]. In response to lipolytic hormones, such as 
noradrenaline, HSL is phosphorylated and con- 
comitantly activated, whereas antilipolytic hormones, 
such as insulin, cause a net dephosphorylation and 
deactivation. 
In addition to the phosphorylation site for activation 
by hormones, HSL has a second phosphorylation site, 
the basal phosphorylation site. Its phosphorylation by 
Abbreviufiom: HSL, hormone-sensitive lipase; FLHSL, full-length 
HSL cDNA; FY HSL, HSL cDNA lacking the 5’.untranslated 
region; LPL. lipoprotein lipase; CAT, chloramphenicol acetyl 
transferase; IgG, immunoglobulin G; DFP, diisopropylfluorophos- 
phate; anti-HSL, the IgG fraction of a rabbit polyclonal antiserum 
prepared using rat adipose tissue HSL lipase; SDS-PAGE, sodium 
dodecylsulfate polyacrylamide gel elcctrophoresis. 
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cyclic AMP-independent kinases does not directly af- 
fect HSL activity [lo]. TI;e basal phosphorylation site 
has recently been identified as Ser-565 in the rat se- 
quence [I 1 J. Its extact function has not been establish- 
ed, but recently it has been proposed to have a 
regulatory, antilipolytic function since its phosphoryla- 
tion, catalyzed by AMP-activated kinase, prevents the 
subsequent phosphorylation of Ser-563 by cylic A.MP- 
dependent protein kinase [11,12]. The HSL catalytic 
site has not been elucidated. However, HSL is inhibited 
by diisopropylfluorophosphate (DFP) (1) and related 
compounds, suggesting that a reactive serine is involv- 
ed. One possible candidate for this reactive serine is 
Ser-423, which is found in the sequence GDSAG. The 
sequence motif GXSXG is found at the active centers of 
most serine proteases [ 131 and has been reported in the 
sequence of all known mammalian and bacterial lipases 
t141. 
To identify the catalytic site of HSL, and to establish 
the functional role of the basal phosphorylation site, 
experiments employing the site-directed mutagenesis 
technique are urgently required. In this communica- 
tion, we report on the deveicrpment of a eukaryotic ex- 
pression system for HSL which allows efficient expres- 
sion of apparently native, catalytically active enzyme, 
the activity of which can be controlled through 
phosphorylation by cylic AMP-dependent protein 
kinase. This expression system should be valuable for 
site-directed mutagenesis experiments to finally identify 
the catalytic site. It should also be useful for determin- 
ing the role of the basal site phosphorylation in the hor- 
monal regulation of HSL activity. 
Puhlislled !JJ~ Hsevier Scietlce Publishers B. V, 139 
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2. EXPERIMENTAL 
2.1. Materials 
Restriction enzymes and DNA modifying enzymes were purchased 
from BRL, except for Bsml, which was obtained from Stratagene. 
The eukaryotic expression vector pSVL was obtained from Phar- 
macia and the shuttle vector Bluescript from Stratagene. F&mid 
DNAs were isolated using the 500 packs from Qiagen. 
2.2. DNA constructs 
A full-length rat HSL cDNA (FLHSL) was constructed from three 
overlapping cDNA fragments [6,15] and ligated into the pSVL vector 
at the Smal site (Fig. I). A second construct (FS - HSL) tacking all but 
the last 13 (of 614) S’-untranslated nucleotides was made utilizing a 
unique Bsm I site in FLHSL. After end filling with T4 DNA 
polymerase [16]. this construct was ligated into the Smal site of pSVL 
(Fig. I). Similarly, pSVL-LPL contains the coding sequences for 
human LPL [19] cloned directionally into the X/r01 and BamHl sites 
of pSVL. 
pKTSV [lg] is a pUC I8 based plasmid construct which carries an 
SV40 origin of replication and expresses CAT activity under the 
regulation of the SV40 early promotor. 
2.3. Tmnsfection 
COS cells, approximately 80% confluent, were transfected with the 
different DNA constructs using 30 pg Lipofectin (BRL) per 60 mm 
tissue culture plate following instructions provided by the manufac- 
EcoAI Barn HI 
turer. 72 h after transfection, cells to be analyzed for RNA were 
harvested by adding the denaturing solution [19] directly to the plates. 
Cells for other analyses were rinsed with 3 ml of 0.9% NaCt and then 
scraped off in 1.5 ml of 0.9% NaCt using a rubber policeman. The 
cells were pelleted by a brief centrifugation at room temperature in a 
microfuge and then homogenized in 3-5 ~01s. of 0.25 M sucrose, 1 
mM EDTA, 1 mM dithioerythritol, 1 mM benzamidine, 2OBg/ml an- 
tipain and 20pg/mI leupeptin using a motordriven homogenizer with 
a teflon pestle. In some experiments, the COS cell homogenates were 
spun at I10000 xg, 4.5 min, 4°C. and the supernatant used for further 
analysis, A fat-depleted 11OOOOxg infranatant of a rat epididymal 
adipose tissue homogenate was prepared [l] from 200 g male Sprague- 
Dawley rats (ALAB. Sweden), fed ad libitum. 
2.4. Enzyme assays and activation by CAMP-dependent protein 
kinase 
HSL was routinely assayed using 1(3)-mono[3H]oleoyl-2-oleyl- 
glycerol (a diacylglycerot ether analoguc) as substrate [20]. One unit 
(U) of enzyme activity is defined as 1 pmol of fatty acid released per 
min at 37°C. Enzyme assays in the presence of HSL inhibitors were 
performed as described [S]. HSL in homogenates (see 2.3) was ac- 
tivated by cylic AMP-dependent protein kinase by incubation at 37°C 
for 30 min with 0.5 mM ATP, 5 mM MgC12, 1 mM dithioerythritol, 
10 mM Na-PPt and the catalytic subunit of cyclic AMP-dependent 
protein kinase (3 ag/ml), purified to near homogeneity from rat 
adipose tissue [9,21]. In controls, the protein kinase was omitted. Ac- 
tivated and control samples were assayed using a 0.5 mM trioleoyl- 
glycerol substram [22] at a pH of 8.3 [9]. 
Subcloning in Rluescript (2 steps1 
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Fig. 1. Construction of plasmids. ThreecDNA fragments (boxed) were subcloned into Bluescript to obtain a fullength cDNA construct (FL-HSL). 
FS-HSL was then obtained as illustrated and the two different constructs were subcloned into the Snral-site of pSVL. PL indicate the polylinker 
of Bluescript. Restriction sites labeled with an asterisk were not reconstituted during the procedure. Figures in parentheses indicate number of 
nucleotides in constructs. 
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2 3. Phosphorylaiion and immrrnoprecipitution __ I 
Aliquots of 110000 x g supernatants or infranatants (see 2.3) were 
phosphorylated by the catalytic subunit of cyclic AMP-dependent 
protein kinase as described above for the activation, except that 0.1 
mM [y-“P]ATP was used and the Na-PPt was exchanged for 100 mM 
NaF. HSL was then immunoprecipitated twice with anti-HSL [23,24]. 
Phosphorylated aliquots, corresponding to approximately 50 ng HSL 
protein, were immunoprecipitated with 150 pg anti-HSL (overnight 
4’C) and 45 mg of extensively prewashed S. aureus protein A (Sigma) 
(30 min. 4°C). After centrifugation (IOOOOxg, 5 min, 4°C). the im- 
munoprecipitates were washed 3 times with I ml of phosphate- 
buffered saline, 0.1% (w/v) N-lauroyl sarcosine, and dissolved in 60 
alof 0.1 M Tris-HCl, pH 7.5, 2% (w/v) SDS by boiling. After adding 
165 al of 0.3 M Tris-HCI, pH 7.5, 45 ~1 of 20% (w/v) Triton X-100 
and 30 /tl of 10% (w/v) N-lauroyl sarcosine, a second im- 
munoprecipitation was performed as above. Throughout the im- 
munoprecipitations and washings NaF was added to 100 mM to in- 
hibit protein phosphatases. The final immunoprecipitates were 
dissolved by boiling in 50 mM Tris-HCI, pH 6.8, 2% (w/v) SDS, 2% 
(W/V) &mercaptoethanol and 5% (w/v) glycerol. 
2.6. ExtracIion of RNA and Northern blol analyses 
Total RNA was isolated using a single-step acid guanidinium thio- 
cyanate/phenol/chloroform extraction [19]. RNA samples were elec- 
trophoresed in 1% agarose, 2.2 M formaldehyde gels, transferred to 
nylon membrane (Schleicher & Schucll) and cross-linked to the mem- 
brane by exposure to ultraviolet light [25]. The blots were hybridized 
with a 1.9 kb rat HSL cDNA probe [6,14], radiolabeled with 
[“P]dCTP to a specific activity of about IO9 cpm/@g [26], in 0.5 M 
sodium phosphate (pH 7.0), 1% (w/v) bovine serum albumin, 1 mM 
EDTA and 7% (w/v) SDS at 60°C overnight. The blots were washed 
twice (20 min each wash) in 15 mM NaCI, 1.5 mM trisodium citrate, 
0.1% SDS at 60°C and exposed to Kodak XAR 5 film. 
Fig. 2. Optimization of HSL expression in transfected COS cells. 
Duplicate plates were transfected with pSVL alone, pSVL-FLHSL or 
pSVL-FS-HSL at 0.1 pg. 1 pg. 5 pg or IOcg per plate and in all cases 
cotransfected with 0.1 +g pKTSV. At day 3 the cells were harvested 
and homogenates prepared and analyzed for HSL activity, total pro- 
tein and CAT activity (for details, see section 2). Shown is the mean 
HSL activity per mg total protein per CAT activity. 
2.1. Other analyses 
CAT assay was performed essentially as described in [27] using ali- 
quots of the same homogenates as used for HSL activity 
measurements (see 2.3). The autoradiograms of the thin layer 
chromatography plates were quantitated by densitometric scanning 
(Joyce-Loebl, Chromoscan 3) at 626 nm. The activity was calculated 
as follows: percent acetylated = (peak areas of acetylated species)/ 
(peak area in acetylated species f counts in nonacetylated chloram- 
phenicol). The CAT activity of the pSVL transfcctcd cells was defined 
as 1 and the CAT activity of other cells normalized against this. 
To examine if the expression of HSL in the CO!3 cells 
could be enhanced by removing most of the long 
5 ‘-untranslated region, a construct was made lacking 
all hut 13 nucleotides of the 5 ‘-untranslated region 
(FS--HSL) (Fig. 1). At all DNA concentrations ex- 
amined, the cDNA lacking 5’-untranslated sequences 
expressed higher levels of HSL than the fu&length 
cDNA (Fig. 2). 
Protein was determined according to Bradford [28] using bovine 
serum albumin as standard. SDS-PAGE was performed in slab gels 
(14 x 14 cm) according to Laemmli [29] with modifications [30]. 
Reference proteins were myosin (Mr, 205 000), ,8-galactosidase 
(116000). glycogen phosphorylase a (97000). human transfcrrin 
(7B 000), bovine serum albumin (66 000). ovalbumin (45 000) and car- 
bonic anhydrase (29000) (all from Sigma). Western blotting was per- 
formed as described in de&ii in [23j using anti-HSL. The Western 
blots were quantitated by densitometric scanning of the autoradio- 
grams. 
The reproducibility of the transfection procedure was 
analyzed by performing transfections in quintuplicates 
with 1 pg each of the pSVL-FLHSL, pSVL-FY-HSL 
and pSVL constructs. The HSL activity of the cell 
homogenates, expressed as mU/mg total protein/CAT 
activity were found to be 11.8 f 2.4 for pSVL-FLHSL, 
30.5 c 2.6 for pSVL-FS-HSL and 4.2 -i-O.4 for pSVL 
(mean * SD). 
The HSL mRNA species found in cells, transfected 
with the different HSL cDNA constructs, were analyz- 
ed by Northern blot analysis. Cells transfected with the 
pSVL-FLHSL and pSVL-FS-HSL constructs expressed 
major HSL mRNA species with apparent sizes of 3.8 kb 
and 3.7 kb, respectively (Fig. 3). The amount of HSL 
mRNA, by derrsitometric scanning of the auto- 
radiogram, was approximately 60% higher for the 
pSVL-FS-HSL construct than for the pSVL-FLHSL 
construct, consistent with the approximately 80% 
higher expression of HSL protein (Fig. 2, 1 fig value). 
The HSL transcripts expressed in COS cells have an ap- 
parent size about 500 nucleotides larger than rat 
adipose tissue HSL mRNA, presumably due to un- 
translated sequences added by the pSVL construct. 
3, RESULTS 
3 .I. Expression of HSL in COS cells 
A full-length rat HSi cDNA (FLHSL) was ligated in- 
to the pSVL vector (Fig. l), a eukaryotic expression 
vector containing the SV40 late promoter and the SV40 
late @yadenylation signal [31,32] (Fig. 1). Homo- 
genates of COY cells, transfected with the pSVL- 
FLHSL construct, exhibited a more than IO-fold in- 
crease in diacylglycerol lipase activity, compared to 
COS cells transfected with the pSVL vector alone or the 
pSVL vector containing a cDNA for human LPL [I71 
(Fig. 2, filled bars). 
3.2. Characterization of the expressed HSL protein 
The HSL activity of the transfected CDS cells was 
analyzed for susceptibility to known HSL inhibitors [l] 
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Fig. 3. Northern blot analysis of COS cells transfected with different 
pSVL-HSL constructs. Polyadenylated RNA (I pg) from rat adipose 
tissue or IO/ig of total RNA from COS cells transfected with 1 hcg of 
either pSVL, pSVL-FLHSL or pSVL-FS-HSL were electrophoresed 
in a 2.2 M formaldehyde, 1% agarose gel and blotted to nylon mem- 
brane. The blot was hybridized with a ‘LP-laheled rat HSL cDNA 
probe, washed and exposed to film for 16 h (for details, see section 2). 
The indicated sizes are calculated from mobility of a RNA size stan- 
dard (BRL). 
including DFP, Hg2+ and anti-HSL [23]. It was found 
that the HSL activity of COS cells, transfected with 
either pSVL-FLHSL or pSVL-FS-HSL, was inhibited 
by these inhibitors to approximately the same extent as 
rat adipose tissue HSL (Table I). The low diacylglycerol 
lipase activity of cells transfected with the pSVL alone, 
142 
on the other hand, was inhibited much less (Table I) in- 
dicating that it was due to another lipase. 
To address the question of how much of the express- 
ed protein was catalytically active, the amount of HSL 
polypeptide in the cells was estimated from Western 
blots, using the 11OOOOxg infranatant of a rat 
epididymal adipose tissue homogenate (see above) as 
reference. The amount of catalytically active HSL was 
estimated, by densitometric scanning, to be between 
7’5% and 80% (range for 2 different transfection ex- 
periments), with no difference between FLHSL and 
FS-HSL (data not illustrated). 
The ability to phosphorylate expressed HSL using 
cyclic AMP-dependent protein kinase was examined in 
110000 x g supernatants of homogenates of cells, 
transfected with either pSVL-FLHSL or pSVL- 
FS-HSL. Immunoprecipitates of 32P-labeled HSL 
showed that the expressed HSL protein could be 
phosphorylated to approximately the same extent as rat 
adipose tissue HSL, when using comparable ratios bet- 
ween the lipase and the kinase (Fig. 4). The exact degree 
of phosphorylation was not determined but it could be 
estimated, based on scanning densitometric analysis of 
the autoradiogram in Fig. 4 and taking into account the 
presence of some catalytically inactive protein in the 
pSVL-FLHSL homogenate (20% for the experiment in 
Fig. 4), to be almost 90% of that found for rat adipose 
tissue HSL. Phosphorylation in the presence of unlabel- 
ed ATP and assaying trioleoylglycerol lipase activity 
demonstrated that the HSL phosphorylation by cyclic 
AMP-dependent protein kinase increased enzyme ac- 
tivity by 46% (46+ 13’70, mean+ SD for n = 5 with the 
same COS cell homogenate). This was comparable to 
the activation of a fat-depleted rat adipose tissue 
homogenate, which was 56% (56a 9070, mean c SD, 
II = 5) under the same conditions, and is in agreement 
with previous findings for activation of crude 
homogenates [33]. 
Tahlc I 
inhibition of diacylglycerol ipase activity in transkcted COS cells by 
HSL activity inhibitors 
Additions Diacylglycerol lipase activity (070 remaining) 
pSVLFL- p-SVL-FS-HSL pSVL Rat adipose 
HSL tissue 
anti-HSL 25.1 ~4.6 18.8k4.2 64.5-c 4.3 11.0~0.5 
DFP 
(lOO/tM) 2.5+-0.1 l.2kO.3 48.6~ 20.4 6.4&I .6 
Hg” 
(IOOrM) 3.9-e I.0 2.1 -co.9 19.1111.3 6.2kO.6 
Homogenates of COS cells transfected with 5 /cg of different pSVL 
constructs as indicated and a homogenate of rat adipose tissue were 
assayed for diacylglycerol lipase activity after preincubation with 
anti-HSL (whole antiserum, diluted IO-fold), DFP or Hg2’, at the in- 
dicated concentrations. Lipase activity is expressed as percent of the 
activity after preincubation with the appropriate control in each case. 
Values are mean f S.D. (n = 3). 
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Fig. 4. Phosphorylation of COS cell-expressed HSL by CAMP- 
dependent protein kinase. Aliquots of 110000 x g supernatants of 
COS cell homogenates, transfected with either pSVL-FLHSL or 
pSVL alone, and an aliquot of an IlOOOOxg infranatant of rat 
adipose tissue were phosphorylated with [3’P]ATP-MgZ’ and CAMP- 
dependent protein kinase (the catalytic subunit). After two immuno- 
precipitations with anti-HSL and S. uurcws protein A, the im- 
munoprecipitates were subjected to SDS-PAGE (8%) followed by 
autoradiography for 6 days. The positions of the reference proteins 
are indicated on the lefthand side of the diagram. 
4. DISCUSSION 
The expressed HSL was almost identical to HSL 
from rat adipose tissue with respect to all examined en- 
zymological and physicochemical properties. The ex- 
pressed HSL activity (activity per mg total protein) was, 
with the optimal cDNA construct and DNA concentra- 
tion (FS-HSL, 5 pug), nearly half of that seen in adipose 
tissue from 200 g rats. The transfection efficiency has 
not been determined, but based on the original report 
describing the use of Lipofectin for transient transfec- 
tions [34], it is reasonable to assume that it is close to 
100%) and that the specific activities measured 
therefore are close to the specific activity of the HSL- 
expressing cells. Removal of 601 of the 614 5’-untrans- 
lated nucleotides resulted in a more efficient expression 
of HSL compared to the FLHSL (Fig. 2). The increase 
in expression was between 45% and 90% depending on 
the DNA concentration used. The fact that the increase 
appeared to be similar at the mRNA and protein level 
suggests an increased transcription rate or an increased 
mRNA stability, rather than an effect on translation. 
The sizes of the HSL mRNA species in the transfected 
COS cells, 3.8 and 3.7 kb for FLHSL and FS-HSL, 
respectively, are approximately what could be expected, 
considering the size of the HSL cDNA introduced in 
each case plus the additional 3’-untranslated sequences 
from the pSVL vector and a poly(A) tail. One slightly 
larger and one smaller hybridizing mRNA were also 
found. These mRNAs probably represent unspliced and 
degraded HSL mRNA, respectively, since they were ab- 
sent from cells transfected with only pSVL. 
The expressed HSL exhibited the same inhibition 
characteristics as rat adipose tissue HSL, and was 
phosphorylated by cylic AMP-dependent protein kinase 
concomitant with an increased enzyme activity. It was 
estimated that at least 50% of the expressed protein was 
catalytically active, and thus most likely in its true 
native conformation. The fact that the degree of 
phosphorylation was higher than the degree of 
catalytically active protein, can probably be explained 
by phosphorylation also of catalytically inactive pro- 
tein, since it has been observed that denatured HSL, 
which has been immobilized on a nitrocellulose mem- 
brane after SDS-PAGE, can be phosphorylated to ap- 
prox. the same extent as native HSL (C. Holm, un- 
published observation). The Iow diacylglycerol lipase 
activity seen in COS cells transfected with the pSVL 
alone, and also in non-transfected COS cells (not il- 
lustrated), is at least to a large extent, due to a neutral 
esterase/lipase other than HSL. Indeed, these cells did 
not express an HSL mRNA and the diacylglycerol 
lipase activity found was inhibited to a considerably 
lower extent with known HSL inhibitors, especially 
anti-HSL. 
The mammalian cell system described in this report 
for expression of apparently native HSL will allow site- 
directed mutagenesis experiments to be performed in 
order to identify the catalytic site and to determine if 
the basal phosphorylation site, as recently proposed 
[l l], has a role in the hormonal regulation of HSL in 
adipocytes. 
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